Lumos Pharma Inc.

05/05/2022 | Press release | Distributed by Public on 05/05/2022 07:06

Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2[...]